Press Releases Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Market Closed - Nasdaq Stockholm Other stock markets 11:29:55 2024-05-13 EDT			5-day change	1st Jan Change
100 ^SEK	+0.20%		0.00%	+27.23%

05-08	Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024
05-08	Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Devyser Diagnostics Q1 - The recognition of Devyser begins	05-10	AQ
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024	05-08	AQ
Invitation to audiocast for Devyser’s Q1 report 2024	05-03	AQ
Devyser partners with Hamilton to automate laboratory NGS workflows	04-23	AQ
Devyser receives MDSAP certification for Brazil	04-16	AQ
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patient	02-29	AQ
Devyser Diagnostics Q4 - Better positioned than ever	02-21	AQ
Devyser Diagnostics AB publishes year-end report for January to December 2023	02-20	AQ
Invitation to audiocast for Devyser’s Q4 report 2023	02-14	AQ
Devyser signs in vitro diagnostic agreement with Illumina to broaden access to its tests	01-08	AQ
Devyser wins tender for non-invasive fetal RHD testing in Wales	12-05	AQ
Devyser Diagnostics Q3 - High sales growth ahead of additional growth drivers	11-10	AQ
Devyser Diagnostics AB publishes quarterly report for July to September 2023	11-09	AQ
Invitation to audiocast for Devyser's Q3 report 2023	23-10-30	AQ
Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research	23-09-13	AQ
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding Brazil	23-09-06	AQ
Devyser Diagnostics Q2 - An unnoticed high-quality growth case	23-08-25	AQ
Devyser Diagnostics AB publishes quarterly report for the period April to June 2023	23-08-23	AQ
Invitation to audiocast for Devyser's Q2 report 2023	23-08-14	AQ
Devyser's NGS products for monitoring of kidney and stem cell transplanted patients receive IVDR approvals	23-07-17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Press Releases

Filters